This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (683) Developmental Problems (80) Mental Health Issues in Adolescence (637) Pharmacology and Pharmaceutics (111) Psychiatry (95)

Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/58031, first published .
Clozapine for Treatment-Resistant Disruptive Behaviors in Youths With Autism Spectrum Disorder Aged 10-17 Years: Protocol for an Open-Label Trial

Clozapine for Treatment-Resistant Disruptive Behaviors in Youths With Autism Spectrum Disorder Aged 10-17 Years: Protocol for an Open-Label Trial

Clozapine for Treatment-Resistant Disruptive Behaviors in Youths With Autism Spectrum Disorder Aged 10-17 Years: Protocol for an Open-Label Trial

Authors of this article:

André Luiz Schuh Teixeira da Rosa1, 2 Author Orcid Image ;   Marina Ribeiro Barreto da Costa1, 2 Author Orcid Image ;   Gabriela Bezerra Sorato2, 3 Author Orcid Image ;   Felipe de Moura Manjabosco2, 3 Author Orcid Image ;   Érica Bonganhi de Bem1, 2 Author Orcid Image ;   Lucas Dellazari2 Author Orcid Image ;   Arthur Bezerra Falcão1, 2 Author Orcid Image ;   Lucas de Oliveira Cia2, 3 Author Orcid Image ;   Olivia Sorato Bezerra4 Author Orcid Image ;   Rogério Boff Borges5, 6 Author Orcid Image ;   Luis Augusto Rohde7, 8, 9, 10 Author Orcid Image ;   Ana Soledade Graeff-Martins1, 2 Author Orcid Image
Article Authors Cited by (2) Tweetations Metrics

Journals

  1. Al-Wahaibi L, Abou-Zied H, Mahmoud M, Youssif B, Bräse S, Rabea S. Design, synthesis, and antiproliferative activity of new 5-ethylsulfonyl-indazole-3-carbohydrazides as dual EGFR/VEGFR-2 kinases inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 2025;40(1) View
  2. Wei J, Dong T. The Effect of Clozapine on Immune‐Related Biomarkers in Schizophrenia Patients. Journal of Biochemical and Molecular Toxicology 2025;39(9) View